Stockscreener 앱 받기
1.255
3.79%
-0.065
전일 마감가:
$1.32
열려 있는:
$1.31
하루 거래량:
170.32K
Relative Volume:
0.01
시가총액:
$50.95M
수익:
-
순이익/손실:
$-20.34M
주가수익비율:
-1.8006
EPS:
-0.697
순현금흐름:
$-15.59M
1주 성능:
-1.55%
1개월 성능:
-50.39%
6개월 성능:
+5.83%
1년 성능:
-43.30%
1일 변동 폭
$1.23
$1.32
1주일 범위
$1.23
$1.465
52주 변동 폭
$0.54
$4.00
Heartbeam Inc Stock (BEAT) Company Profile
명칭
Heartbeam Inc
전화
408-899-4443
주소
2118 WALSH AVE., SUITE 210, SANTA CLARA
Compare BEAT vs VEEV, TEM, BTSG, HQY, DOCS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
1.27 | 52.95M | 0 | -20.34M | -15.59M | -0.697 |
|
VEEV
Veeva Systems Inc
|
170.84 | 29.10B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
50.03 | 9.54B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
38.44 | 7.22B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
74.68 | 6.57B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
24.61 | 4.80B | 550.17M | 201.35M | 232.07M | 1.00 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-11 | 업그레이드 | The Benchmark Company | Speculative Buy → Buy |
| 2025-12-08 | 개시 | H.C. Wainwright | Buy |
| 2025-10-31 | 개시 | Roth Capital | Buy |
| 2020-09-11 | 개시 | Needham | Buy |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-08-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | 재확인 | Dougherty & Company | Buy |
| 2018-07-26 | 재확인 | Lake Street | Buy |
| 2018-04-26 | 재확인 | The Benchmark Company | Buy |
| 2018-02-23 | 재확인 | Dougherty & Company | Buy |
| 2017-11-08 | 재확인 | Dougherty & Company | Buy |
| 2017-10-26 | 개시 | Raymond James | Outperform |
| 2017-10-24 | 개시 | SunTrust | Buy |
| 2017-08-09 | 재확인 | Dougherty & Company | Buy |
| 2017-07-19 | 재확인 | The Benchmark Company | Buy |
| 2017-04-11 | 재확인 | Dougherty & Company | Buy |
| 2016-12-02 | 개시 | Dougherty & Company | Buy |
| 2016-09-13 | 개시 | Sidoti | Buy |
| 2016-08-03 | 재확인 | The Benchmark Company | Buy |
| 2015-07-28 | 재확인 | Dougherty & Company | Buy |
| 2013-10-24 | 개시 | The Benchmark Company | Buy |
| 2013-08-21 | 개시 | Dougherty & Company | Buy |
모두보기
Heartbeam Inc 주식(BEAT)의 최신 뉴스
HeartBeam Files $100 Million Mixed Shelf - marketscreener.com
Is HeartBeam Inc. Equity Warrant stock undervalued vs historical averagesWeekly Investment Recap & Real-Time Buy Signal Alerts - mfd.ru
Bryan Humbarger Named Chief Commercial Officer at HeartBeam - Medical Product Outsourcing
Aug Patterns: Can HeartBeam Inc deliver alpha2025 Price Momentum & High Return Trade Guides - baoquankhu1.vn
Market Recap: Does HeartBeam Inc Equity Warrant have pricing powerRecession Risk & Advanced Technical Signal Analysis - baoquankhu1.vn
HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN
Trend Review: Does HeartBeam Inc Equity Warrant have pricing power2025 Earnings Surprises & Detailed Earnings Play Alerts - baoquankhu1.vn
HeartBeam names Bryan Humbarger as CCO - Medical Buyer
US Market Wrap: How volatile is Empire State Realty OP LP Limited Partnership stockJuly 2025 Rallies & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
HeartBeam appoints Bryan Humbarger as chief commercial officer By Investing.com - Investing.com Nigeria
HeartBeam (BEAT) Appoints Bryan Humbarger as Chief Commercial Officer - NewMediaWire
Meme Stocks: Is CTGO on track to beat earningsTrend Reversal & Growth Focused Investment Plans - baoquankhu1.vn
HeartBeam (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer - Digital Journal
Heartbeam, Inc. Appoints Bryan Humbarger as Chief Commercial Officer, Effective January 22, 2026 - marketscreener.com
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer - 01net
HeartBeam appoints Bryan Humbarger as chief commercial officer - Investing.com
Sectors Review: Can HeartBeam Inc maintain its current growth rate2025 Technical Patterns & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Trend Review: Is GSR III Acquisition Corp. showing insider buyingWeekly Stock Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
Activity Recap: How does Roper Technologies Inc perform in inflationary periodsMarket Trend Review & Breakout Confirmation Alerts - baoquankhu1.vn
Dow Update: Should value investors consider HeartBeam IncJuly 2025 PreEarnings & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Recap Report: Can HeartBeam Inc Equity Warrant stock sustain revenue growthPortfolio Gains Report & Technical Pattern Recognition Alerts - Bộ Nội Vụ
Aug Gainers: Should value investors consider HeartBeam Inc2025 Bull vs Bear & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
FDA Clearance for HeartBeam (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup - TradingView — Track All Markets
What Wall Street predicts for HeartBeam Inc. Equity Warrant stock price2025 Historical Comparison & Weekly Watchlist of Top Performers - ulpravda.ru
FDA Clearance for HeartBeam (BEAT) Highlighted in Medical Device Approvals Roundup - NewMediaWire
About Us - FinancialContent
How HeartBeam Inc. stock performs in interest rate cyclesQuarterly Market Review & Fast Entry High Yield Stock Tips - Улправда
Will HeartBeam Inc. stock benefit from automationQuarterly Market Summary & Technical Entry and Exit Tips - ulpravda.ru
Is HeartBeam Inc. Equity Warrant stock safe for conservative investorsMarket Growth Review & Accurate Entry/Exit Alerts - ulpravda.ru
What sentiment indicators say about HeartBeam Inc. stock2025 Technical Overview & Short-Term Trading Alerts - Улправда
Can HeartBeam Inc. Equity Warrant stock outperform in 2025 bull marketQuarterly Trade Report & Stepwise Trade Signal Guides - Улправда
Is HeartBeam Inc. Equity Warrant stock a safe haven assetRecession Risk & Short-Term High Return Strategies - Улправда
AeroVironment Stock Surges: Military Gains Explored - StocksToTrade
Will HeartBeam Inc. Equity Warrant stock benefit from upcoming earnings reports2025 Retail Activity & Daily Market Momentum Tracking - ulpravda.ru
FDA clearances and approvals: J&J, Abbott, Edwards Lifesciences - Modern Healthcare News
Can HeartBeam Inc. stock hit analyst price targetsGap Fill Strategies & Low Risk Capital Growth - ulpravda.ru
HeartBeam (BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - NewMediaWire
HeartBeam (NASDAQ: BEAT) to attend JP Morgan 2026 annual healthcare conference - MSN
HeartBeam (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - TradingView — Track All Markets
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference - 01net
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - FinancialContent
Trend Recap: Is HeartBeam Inc stock recession proofMarket Trend Review & Weekly Watchlist for Consistent Profits - moha.gov.vn
How HeartBeam Inc. Equity Warrant stock reacts to global recession fearsGlobal Trade Effects & Small Budget Trading Ideas - bollywoodhelpline.com
Pharma News: What sentiment indicators say about HeartBeam Inc stockRisk Management & High Conviction Investment Ideas - moha.gov.vn
HeartBeam seeks FDA nod for ECG synthesis software - MSN
HeartBeam Stock Slumps After FDA Refuses Clearance For ECG Software - MSN
Heartbeam Inc (BEAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
8.13%
1.70%
자본화:
|
볼륨(24시간):